INE485C01029
INE485C01029
IOL CHEMICALS & PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 23.078.100.000 | 20.681.900.000 | 11.6% |
| Cost of Revenue | 15.162.500.000 | 14.139.500.000 | 7.2% |
| Gross Profit | 7.915.600.000 | 6.542.400.000 | 21.0% |
| 6.019.000.000 | 5.236.400.000 | 14.9% | |
| Operating Income | 1.896.600.000 | 1.306.000.000 | 45.2% |
| Pretax Income | 1.843.600.000 | 1.379.600.000 | 33.6% |
| Net Income Common Stockholders | 1.376.400.000 | 1.010.700.000 | 36.2% |
| -- | -- | -- | |
| -- | -- | -- |